Please use this identifier to cite or link to this item:
Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the PAVES Study
Authors: Готько, Євген Степанович
Tamás Pintera
Zandra Klippel
Alvydas Cesas
Adina Croitoru
Jochen Decaestecker
Peter Gibbs
Jacek Jassem
Galina Kurteva
Jan Novotny
Seamus O’Reilly
Tomas Salek
Maureen Reiner
Keywords: Pegfilgrastim, colorectal cancer, febrile neutropenia, overall survival
Issue Date: 2013
Type: Text
Publication type: Стаття
Appears in Collections:Наукові публікації кафедри радіології та онкології

Files in This Item:
File Description SizeFormat 
Abstract.PDF302.54 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.